Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS Registry.

Niklas FrahmDavid EllenbergerAlexander StahmannFiras FneishDaniel LüfteneggerHans C SalmenKsenija SchirduanTom P A SchaakPeter FlacheneckerChristoph KleinschnitzFriedemann PaulDagmar KreftingUwe K ZettlMelanie PetersClemens Warnke

Published in: Therapeutic advances in neurological disorders (2024)

The initial use of MME DMTs was among the strongest predictors of DMT discontinuation in a large German retrospective MS cohort, arguing for the need for prospective treatment strategy trials, not only but also on the initial broad use of HE DMTs in PwMS.

Keyphrases

multiple sclerosis
mass spectrometry
ms ms
cross sectional
replacement therapy